Similar Items: Repurposing dihydroartemisinin as a novel anticancer agent against colorectal cancer stem cells
- In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies
- Autocrine motility factor peptide enhances curcumin/tetrahydrocurcumin activity against colorectal cancer cells in association with glucose-6-phosphate dehydrogenase downregulation and oxidative stress
- Correction to ‘Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway’
- Identifying gene expression signatures for risk stratification of postoperative adjuvant chemotherapy in colorectal cancer
- Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study
- Targeting TNBC: core–shell polycationic polyurea dendrimers with inherent anticancer activity